| Primary |
| Hiv Infection |
62.6% |
| Acquired Immunodeficiency Syndrome |
12.4% |
| Drug Use For Unknown Indication |
4.6% |
| Antiretroviral Therapy |
4.2% |
| Antiviral Treatment |
4.2% |
| Product Used For Unknown Indication |
2.3% |
| Hypertension |
2.0% |
| Hepatitis C |
1.1% |
| Factor Viii Deficiency |
0.8% |
| Insomnia |
0.8% |
| Depression |
0.7% |
| Prophylaxis |
0.6% |
| Acute Hiv Infection |
0.6% |
| Antifungal Prophylaxis |
0.6% |
| Gastritis |
0.6% |
| Anxiety |
0.5% |
| Tuberculosis |
0.5% |
| Antibiotic Prophylaxis |
0.4% |
| Opportunistic Infection Prophylaxis |
0.4% |
| Pain |
0.4% |
|
| Vomiting |
13.4% |
| Rash |
11.3% |
| Myocardial Infarction |
9.7% |
| Pyrexia |
9.1% |
| Urticaria |
7.0% |
| Thrombocytopenia |
5.4% |
| Transaminases Increased |
5.4% |
| Weight Decreased |
5.4% |
| Nausea |
4.3% |
| Death |
3.8% |
| Portal Hypertension |
3.8% |
| Hypersensitivity |
2.7% |
| Respiratory Failure |
2.7% |
| Viral Infection |
2.7% |
| White Blood Cell Count Decreased |
2.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.2% |
| Liver Function Test Abnormal |
2.2% |
| Malaise |
2.2% |
| Renal Failure Chronic |
2.2% |
| Rhabdomyolysis |
2.2% |
|
| Secondary |
| Hiv Infection |
68.5% |
| Acquired Immunodeficiency Syndrome |
7.0% |
| Product Used For Unknown Indication |
5.4% |
| Drug Use For Unknown Indication |
2.9% |
| Antiviral Treatment |
2.8% |
| Hypertension |
1.8% |
| Infection |
1.7% |
| Maternal Exposure Timing Unspecified |
1.4% |
| Drug Exposure During Pregnancy |
1.4% |
| Antiretroviral Therapy |
1.0% |
| Hiv Test Positive |
0.9% |
| Hepatitis C |
0.9% |
| Diarrhoea |
0.7% |
| Haemophilia |
0.6% |
| Atypical Mycobacterial Infection |
0.6% |
| Insomnia |
0.5% |
| Depression |
0.5% |
| Diabetes Mellitus |
0.5% |
| Ill-defined Disorder |
0.5% |
| Oral Candidiasis |
0.5% |
|
| Vomiting |
8.0% |
| Renal Failure Acute |
7.3% |
| Thrombocytopenia |
6.9% |
| Drug Exposure During Pregnancy |
6.1% |
| Myocardial Infarction |
5.7% |
| Renal Failure Chronic |
5.7% |
| Renal Impairment |
5.3% |
| Renal Tubular Disorder |
5.3% |
| Death |
5.0% |
| Pancytopenia |
5.0% |
| Varices Oesophageal |
5.0% |
| Microcephaly |
4.6% |
| Pulmonary Hypertension |
4.6% |
| Pyrexia |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Weight Decreased |
3.8% |
| Haemorrhage Intracranial |
3.4% |
| Rash |
3.4% |
| Renal Failure |
3.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.1% |
|
| Concomitant |
| Hiv Infection |
61.6% |
| Product Used For Unknown Indication |
7.3% |
| Drug Use For Unknown Indication |
5.3% |
| Acquired Immunodeficiency Syndrome |
4.3% |
| Antifungal Prophylaxis |
2.4% |
| Hiv Test Positive |
1.8% |
| Antiretroviral Therapy |
1.8% |
| Diabetes Mellitus |
1.8% |
| Hypertension |
1.8% |
| Prophylaxis |
1.4% |
| Mycobacterium Avium Complex Infection |
1.2% |
| Pain |
1.2% |
| Kaposi's Sarcoma Aids Related |
1.2% |
| Depression |
1.2% |
| Insomnia |
1.2% |
| Drug Exposure During Pregnancy |
1.0% |
| Toxoplasmosis Prophylaxis |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Hepatitis C |
0.8% |
| Cerebral Toxoplasmosis |
0.8% |
|
| Vomiting |
11.1% |
| Renal Failure |
10.1% |
| Rash Maculo-papular |
7.7% |
| Renal Impairment |
7.2% |
| Weight Decreased |
6.8% |
| Aspartate Aminotransferase Increased |
6.3% |
| Pyrexia |
6.3% |
| Renal Failure Acute |
6.3% |
| Tubulointerstitial Nephritis |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Pulmonary Hypertension |
3.4% |
| Abortion Spontaneous |
2.9% |
| Colitis |
2.9% |
| Depression |
2.9% |
| Myocardial Infarction |
2.9% |
| Nausea |
2.9% |
| Pain In Extremity |
2.9% |
| Pancreatitis |
2.9% |
| Rectal Cancer |
2.9% |
| Urinary Tract Infection |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
89.8% |
| Hiv Infection |
8.2% |
| Analgesic Therapy |
2.0% |
|
| Agranulocytosis |
50.0% |
| Drug Interaction |
50.0% |
|
